Mark Cuban’s Cost Plus Drug Company (MCCPDC) has partnered with Posterity Health to provide males with access to medications for infertility, sexual dysfunction, and low testosterone. Posterity Health is a digital male fertility clinic that offers reproductive urology services. MCCPDC aims to make medications more affordable and accessible while promoting better health and encouraging action for medical conditions. This partnership aims to break the stigma around male fertility and improve access to care for men’s sexual health.
Mark Cuban Cost Plus Drug Company (MCCPDC) has announced a partnership with male fertility and sexual healthcare company Posterity Health to provide males access to medications to treat infertility, sexual dysfunction and low testosterone.
Posterity Health is a digital male fertility clinic providing access to reproductive urologists who diagnose and treat sexual health and male fertility issues. The company offers sperm cryopreservation, in-clinic or in-home fertility testing, vasectomy and vasectomy reversal.
“We started Cost Plus Drugs to make medications more affordable and accessible. In addition, we hope to make people healthier and to encourage those impacted by medical conditions to take action,” Mark Cuban, founder of Cost Plus Drugs, said in a statement.
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
“It is time to break the stigma around male fertility and men’s sexual health. Treatment for these conditions is often life-changing. Working together with Posterity Health, we can help more men receive the care and treatment they need to become healthier fathers.”
THE LARGER TREND
Earlier this month, MCCPDC announced it is working with Coherus Biosciences to sell Yusimry, a biosimilar version of top-seller Humira, at a discounted price. The medication treats psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, Crohn’s disease and other conditions.
Cuban expressed his excitement about the partnership to MobiHealthNews in an email, saying, “Coherus’s Yusimry is a game changer. Having an alternative to Humira that is affordable will improve the lives of patients everywhere.”
In April the company announced a collaboration with Seattle-based Zócalo Health, a virtual healthcare service for Latino patients, meant to expand Zócalo members’ access to lower-cost prescription medication.
The company has developed numerous other partnerships, including with California-based EmsanaRx and Tennessee-based RxPreferred Benefits. It also collaborates with diabetes and chronic disease management company Diathrive Health, and with cancer care support company OncoPower.
MCCPDC was integrated into Rightway Health’s platform, so allowing the pharmacy benefit manager’s members access to MCCPDC. Last year, MCCPDC announced its first health plan partnership with Capital Blue Cross, which allows Capital’s members to use their insurance cards at MCCPDC directly.
Source: MobihealthNews
